A study to compare tablet and paste form of turmeric to treat gum infection.

Phase 4

Active, not recruiting

• Conditions: Chronic gingivitis,

• Registration Number: CTRI/2023/10/059242
• Lead Sponsor: Dr Ananya Prabhu

Brief Summary

The study is conducted among people who have chronic gingivitis( gum infection) due to plaque formation. This is a randomized multi-arm clinical trial that has three groups. Group 1: Gold standard/standard procedure- Ultrasonic scaling, Group 2: 30mg Nanocurcumin Capsule and Group 3: Nanocurcumin gel. Nanocurcumin are used in the treatment of gingivitis. This study is to compare the effectiveness of nano curcumin capsule versus the gel.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-11
• Last Update Posted: 2024-10-15

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients with signs of generalized plaque-induced gingivitis.
• Patient having at least 20 teeth.

Exclusion Criteria

• Patients with some systemic disease; 2.
• Patients undergoing treatment for periodontal disease; 3.
• Individuals who have used broad-spectrum antibiotics within the last 3 months.; 4.
• Individuals who have used an antimicrobial mouth rinse within the last two weeks.; 5.
• Pregnant women; 6.
• Patients who are allergic to turmeric; 7.
• Patients with a history of gallstone and/or biliary obstruction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plaque index (PI), modified gingival index (MGI),	Baseline, Day 7 and Day 14

Secondary Outcome Measures

Name	Time	Method
papillary bleeding index (PBI)	Baseline, Day 7 and Day 14

Trial Locations

Locations (1)

T.M.A Pai Hospital; 🇮🇳 Udupi, KARNATAKA, India

T.M.A Pai Hospital

🇮🇳Udupi, KARNATAKA, India

Dr Deepak Singhal

Principal investigator

09379060983

dk.singhal@manipal.edu